158 related articles for article (PubMed ID: 9299260)
21. [Study on the mitochondrion DNA mutation in tumor tissues of gynecologic oncology patients].
Li HX; Zhong S; Li CH
Zhonghua Fu Chan Ke Za Zhi; 2003 May; 38(5):290-3. PubMed ID: 12895314
[TBL] [Abstract][Full Text] [Related]
22. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.
Cierniková S; Tomka M; Kovác M; Stevurková V; Zajac V
Neoplasma; 2006; 53(2):97-102. PubMed ID: 16575464
[TBL] [Abstract][Full Text] [Related]
23. [Analysis of BRCA1 mutations in Chinese patients with early onset breast cancer and affected relatives].
Hu Z; Wu J; Lu JS; Luo JM; Han QX; Shen ZZ; Shao ZM
Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):657-9. PubMed ID: 15777502
[TBL] [Abstract][Full Text] [Related]
24. KLF6: mutational analysis and effect on cancer cell proliferation.
Yin D; Komatsu N; Miller CW; Chumakov AM; Marschesky A; McKenna R; Black KL; Koeffler HP
Int J Oncol; 2007 Jan; 30(1):65-72. PubMed ID: 17143513
[TBL] [Abstract][Full Text] [Related]
25. The novel exon 11 mutation of BRCA1 gene in a high-risk family.
Cierniková S; Tomka M; Sedláková O; Reinerová M; Stevurková V; Kovác M; Cente M; Ilenciková D; Bella V; Zajac V
Neoplasma; 2003; 50(6):403-7. PubMed ID: 14689060
[TBL] [Abstract][Full Text] [Related]
26. Novel somatic mutations in the BRCA1 gene in sporadic breast tumors.
Janatova M; Zikan M; Dundr P; Matous B; Pohlreich P
Hum Mutat; 2005 Mar; 25(3):319. PubMed ID: 15712267
[TBL] [Abstract][Full Text] [Related]
27. [Mutations in the BRCA1 gene in young Spanish women with breast cancer].
Díez Gibert O; del Río E; Domènech M; Hernández EM; Sanz J; Brunet J; Alonso MC; Baiget M
Med Clin (Barc); 1999 Jan; 112(2):51-4. PubMed ID: 10065429
[TBL] [Abstract][Full Text] [Related]
28. High sensitivity of detection of TP53 somatic mutations by fluorescence-assisted mismatch analysis.
Tessitore A; Di Rocco ZC; Cannita K; Ricevuto E; Toniato E; Tosi M; Ficorella C; Frati L; Gulino A; Marchetti P; Martinotti S
Genes Chromosomes Cancer; 2002 Sep; 35(1):86-91. PubMed ID: 12203794
[TBL] [Abstract][Full Text] [Related]
29. Infrequent p53 gene mutations and lack of p53 protein expression in clear cell sarcoma of the kidney: immunohistochemical study and mutation analysis of p53 in renal tumors of unfavorable prognosis.
Hsueh C; Wang H; Gonzalez-Crussi F; Lin JN; Hung IJ; Yang CP; Jiang TH
Mod Pathol; 2002 Jun; 15(6):606-10. PubMed ID: 12065773
[TBL] [Abstract][Full Text] [Related]
30. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.
Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE
Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974
[TBL] [Abstract][Full Text] [Related]
31. Identification of germline BRCA1 and BRCA2 genetic alterations in Greek breast cancer moderate-risk and low-risk individuals--correlation with clinicopathological data.
Kataki A; Gomatos I; Pararas N; Armakolas A; Panousopoulos D; Karantzikos G; Voros D; Zografos G; Markopoulos C; Leandros E; Konstadoulakis M
Clin Genet; 2005 Apr; 67(4):322-9. PubMed ID: 15733268
[TBL] [Abstract][Full Text] [Related]
32. Missense alterations of BRCA1 gene detected in diverse cancer patients.
Shen D; Wu Y; Chillar R; Vadgama JV
Anticancer Res; 2000; 20(2B):1129-32. PubMed ID: 10810408
[TBL] [Abstract][Full Text] [Related]
33. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
[TBL] [Abstract][Full Text] [Related]
34. [p53 gene mutation determined by single-strand conformational polymorphism and DNA sequencing analysis in pleomorphic adenoma of salivary gland].
Wang J; Dong F; Yong P
Zhonghua Kou Qiang Yi Xue Za Zhi; 1999 Sep; 34(5):298-300. PubMed ID: 11776898
[TBL] [Abstract][Full Text] [Related]
35. Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer.
Steinmann D; Bremer M; Rades D; Skawran B; Siebrands C; Karstens JH; Dörk T
Br J Cancer; 2001 Sep; 85(6):850-8. PubMed ID: 11556836
[TBL] [Abstract][Full Text] [Related]
36. Optimization of PCR and electrophoresis conditions enhances mutation analysis of the BRCA1 gene.
Lallas TA; Buller RE
Mol Genet Metab; 1998 Jul; 64(3):173-6. PubMed ID: 9719625
[TBL] [Abstract][Full Text] [Related]
37. TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis.
de Anta JM; Jassem E; Rosell R; Martínez-Roca M; Jassem J; Martínez-López E; Monzó M; Sánchez-Hernández JJ; Moreno I; Sánchez-Céspedes M
Oncogene; 1997 Dec; 15(24):2951-8. PubMed ID: 9416838
[TBL] [Abstract][Full Text] [Related]
38. Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma.
Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ
Gynecol Oncol; 2000 Jul; 78(1):10-5. PubMed ID: 10873402
[TBL] [Abstract][Full Text] [Related]
39. Analysis of the p16 tumor suppressor gene in early-stage prostate cancer.
Gu K; Mes-Masson AM; Gauthier J; Saad F
Mol Carcinog; 1998 Mar; 21(3):164-70. PubMed ID: 9537647
[TBL] [Abstract][Full Text] [Related]
40. BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer.
Seo JH; Cho DY; Ahn SH; Yoon KS; Kang CS; Cho HM; Lee HS; Choe JJ; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS; Son GS; Lee JB; Koo BH
Hum Mutat; 2004 Oct; 24(4):350. PubMed ID: 15365993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
